Oral PTH(1-34) PK and PD Study in Patients With Hypoparathyroidism

NCT03516773 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypoparathyroidism

Interventions

DRUG: EB612 (EBP05)
DRUG: NATPARA/NATPAR

Sponsor

Entera Bio Ltd.